Vaccine Development Process

FDA refuses review of mRNA flu vaccine

FDA rejects Moderna’s mRNA flu vaccine application - for reasons with no basis in the law

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine. The agency’s decision, which Moderna announced in a press release on Feb.

· 20h

FDA Declines to Review Moderna’s mRNA Flu Vaccine Application

· 14h · on MSN

FDA refuses to review Moderna’s new flu shot

Scientific American · 1d

FDA won’t consider a new mRNA vaccine for flu, despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

· 1d

Moderna says FDA refuses its application for new mRNA flu vaccine

· 1d

FDA refuses to review Moderna's mRNA flu shot

· 12h

FDA defends its decision to refuse review of Moderna's flu vaccine

Moderna said it was notified that the health regulator will not initiate a review of its application in a letter, signed by Center Director Vinay Prasad, which cited the lack of an "adequate and well-...

· 1d

F.D.A. Refuses to Review Moderna Flu Vaccine

· 1d

FDA refuses to review Moderna’s mRNA flu vaccine application

Forbes

Under RFK Jr., Vaccine Development Is Facing Unprecedented Challenges

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between autism and certain vaccines, as well as changes to the ...

News Medical on MSN

UVA Health scientists pioneer a new way to create vaccines far more quickly than ever before

UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly and inexpensively than ever before. The University of Virginia School of Medicine's Steven L.

STAT

U.S. health officials inject new uncertainty into approval process for Covid boosters

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on Signal at hbranswell.01. Confusion over the Food and Drug ...

pharmaphorum

AMR and vaccines: Can universal coverage avert a post-antibiotic era?

A universal vaccine would work to help combat the development of AMR in several ways. Firstly, it would protect the individual from getting infected. Prevention of primary infection removes the potential for development of complications that may lead to secondary infection, which could require antibiotics.